Medical education on cannabis and cannabinoids: Perspectives, challenges, and opportunities

Clinical Pharmacology and Therapeutics

Volumn 97, Issue 6, 2015, Pages 548-550

  Ware, M A ^a,b   Ziemianski, D ^b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b Canadian Consortium for the Investigation of Cannabinoids   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; MEDICAL CANNABIS;

CURRICULUM; EDUCATIONAL TECHNOLOGY; HEALTH CARE PERSONNEL; HUMAN; MEDICAL EDUCATION; PRIORITY JOURNAL; REVIEW; PHYTOTHERAPY;

CANNABINOIDS; CURRICULUM; EDUCATION, MEDICAL; HUMANS; MEDICAL MARIJUANA; PHYTOTHERAPY;

EID: 84938942853     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1002/cpt.103     Document Type: Review

References (5)

1. Gaoni, Y. & Mechoulam, R. Isolation, structure, and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86, 1646-1647 (1964).
2. Brody, H. Pharmaceutical industry financial support for medical education: benefit, or undue influence? J. Law Med. Ethics 37, 451-460 (2009).
3. Ziemianski, D. et al. Cannabinoids in clinical practice: experiences and educational needs. Canadian Pain Society Abstracts, 2012. Pain Res. Manag. 17, 180-233 (2012).
4. Pertwee, R.G. (ed.). Handbook of cannabis. (Oxford University Press, Oxford, UK, 2014).
5. Grotenhermen, F. Pharmacology of cannabinoids. Neuroendocrinol. Lett. 25, 14-23 (2004).